Stock A009290 KWANG DONG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Kwang Dong Pharmaceutical Co., Ltd.

Equities

A009290

KR7009290008

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 17/05/2024 am IST 		5-day change 1st Jan Change
6,880 KRW +0.88% Intraday chart for Kwang Dong Pharmaceutical Co., Ltd. +1.18% -7.40%
18/03 Kwang Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
29/01 Zhaoke Ophthalmology Grants Kwangdong Pharma Rights to Distribute Eye Drop in Korea MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,77,977 2,63,211 4,21,076 3,05,229 2,44,840 2,97,799
Enterprise Value (EV) 1 2,58,924 2,63,357 3,81,508 2,49,574 1,74,214 3,27,259
P/E ratio 12.4 x 11.4 x 9.16 x 12.7 x 10.1 x 8.14 x
Yield 1.17% 1.2% 0.98% 1.35% 1.68% 1.35%
Capitalization / Revenue 0.24 x 0.21 x 0.34 x 0.23 x 0.17 x 0.2 x
EV / Revenue 0.22 x 0.21 x 0.31 x 0.19 x 0.12 x 0.22 x
EV / EBITDA 5.04 x 4.35 x 5.75 x 4.23 x 3.33 x 5.95 x
EV / FCF 7.81 x 15.8 x -21.5 x 4.19 x 4.92 x -5.58 x
FCF Yield 12.8% 6.33% -4.66% 23.9% 20.3% -17.9%
Price to Book 0.68 x 0.62 x 0.88 x 0.61 x 0.47 x 0.55 x
Nbr of stocks (in thousands) 40,581 39,581 41,081 41,081 41,081 40,081
Reference price 2 6,850 6,650 10,250 7,430 5,960 7,430
Announcement Date 21/03/19 12/03/20 18/03/21 17/03/22 16/03/23 18/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 11,80,220 12,38,255 12,43,770 13,38,182 14,31,545 15,14,454
EBITDA 1 51,397 60,605 66,299 59,045 52,262 54,974
EBIT 1 33,945 41,803 46,591 44,936 38,244 42,070
Operating Margin 2.88% 3.38% 3.75% 3.36% 2.67% 2.78%
Earnings before Tax (EBT) 1 31,396 36,770 62,951 34,329 36,291 49,019
Net income 1 22,345 23,058 45,370 24,019 24,174 36,966
Net margin 1.89% 1.86% 3.65% 1.79% 1.69% 2.44%
EPS 2 550.8 581.7 1,119 584.3 588.0 913.0
Free Cash Flow 1 33,171 16,665 -17,775 59,535 35,407 -58,701
FCF margin 2.81% 1.35% -1.43% 4.45% 2.47% -3.88%
FCF Conversion (EBITDA) 64.54% 27.5% - 100.83% 67.75% -
FCF Conversion (Net income) 148.45% 72.27% - 247.87% 146.47% -
Dividend per Share 2 80.00 80.00 100.0 100.0 100.0 100.0
Announcement Date 21/03/19 12/03/20 18/03/21 17/03/22 16/03/23 18/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 146 - - - 29,460
Net Cash position 1 19,054 - 39,568 55,655 70,627 -
Leverage (Debt/EBITDA) - 0.002416 x - - - 0.5359 x
Free Cash Flow 1 33,171 16,665 -17,775 59,535 35,407 -58,701
ROE (net income / shareholders' equity) 5.19% 5.16% 9.6% 4.96% 4.97% 6.94%
ROA (Net income/ Total Assets) 2.92% 3.43% 3.59% 3.28% 2.63% 2.62%
Assets 1 7,66,106 6,72,882 12,64,733 7,33,160 9,18,253 14,13,003
Book Value Per Share 2 10,087 10,686 11,627 12,151 12,593 13,588
Cash Flow per Share 2 1,679 1,927 1,336 2,044 2,521 1,930
Capex 1 18,827 12,637 5,262 23,795 25,383 34,785
Capex / Sales 1.6% 1.02% 0.42% 1.78% 1.77% 2.3%
Announcement Date 21/03/19 12/03/20 18/03/21 17/03/22 16/03/23 18/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
KWANG DONG PHARMACEUTICAL CO., LTD. Stock Kwang Dong Pharmaceutical Co., Ltd.
-7.40% 203M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+21.59% 44.15B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+23.03% 23.02B
SANDOZ GROUP AG Stock Sandoz Group AG
+18.22% 15.33B
CIPLA LIMITED Stock Cipla Limited
+12.26% 13.74B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+52.55% 12.16B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-10.02% 6.84B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+13.88% 5.66B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A009290 Stock
  4. Financials Kwang Dong Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW